Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Pharmacists need to ensure anticoagulants are held appropriately before and after surgery to prevent complications from for CIED infections.
The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Intranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Ready-to-use glucagon simplifies hypoglycemia rescue by providing easy-to-use options for patients and caregivers.
The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
This inflammation of the colon poses a substantial burden to patients and the health care system.
George Wang discusses the widespread financial barriers patients with cancer face, the environmental and economic toll of oncology drug waste, and how pharmacist-supported medication donation programs can safely and legally redistribute surplus cancer treatments to patients in need.
Patient fears can be mitigated by pharmacists who use targeted communication strategies to bolster acceptance.
When helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
CPX-351 shows promise for younger adults with therapy-related AML, offering improved survival post-transplant despite lower initial remission rates.
Oncology pharmacists could be canaries in the coal mine of health care systems.
PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.
Panelists discuss how anticipated updates to cholesterol guidelines and related cardiovascular-kidney-metabolic health (CKM) guidelines this year are expected to shape low-density lipoprotein cholesterol (LDL-C) management strategies and influence treatment recommendations for high-risk patients.
The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Market access offers pharmacists a dynamic career path.
Gold bagging integrates health system-owned specialty pharmacies with clinical workflows to enhance safety, efficiency, outcomes, and patient experience.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Emma Murter, PharmD, MPH, and Madison N. Irwin, PharmD, BCPS, discuss the potential role of low-dose naltrexone in managing chronic pain in palliative care, highlighting its anti-inflammatory properties, limited adverse effects, and current evidence gaps—particularly in comparison to traditional opioids and adjuvant analgesics.
Pharmacists should get involved in all the various aspects of their business and with the different professional groups available.
Investigators assessed the efficacy of BsAb5003 in treating multiple myeloma, with the results showing that the therapy may be an effective treatment approach.
Experts share operational challenges and patient care implications of the Inflation Reduction Act's (IRA) drug pricing reforms.
The FDA is warning of rare severe itching after stopping long-term use of popular allergy medications cetirizine and levocetirizine, urging patient education.
Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
The hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.